Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy
Journal of the American Society of Nephrology, 01/18/08
Parving H-H et al. - Losartan treatment reduced renal outcomes in proteinuric patients with type 2 diabetes in the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study. It is unknown whether an insertion (I)/deletion (D) polymorphism in the angiotensin I-converting enzyme (ACE) gene predicts renal outcomes and death and influences the effect of losartan in these patients...Proteinuric type 2 diabetic patients with the D allele of the ACE gene have an unfavorable renal prognosis, which can be mitigated and even improved by losartan
| Previous Article | Next Article |
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan
Lupus, 06/15/09
Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes
Journal of Internal Medicine, 07/01/09
Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPAR and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes
Nephrology Dialysis Transplantation, 06/09/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
American Journal of Kidney Diseases, 06/23/09
The factors for progression of the diabetic nephropathy: Management and evolution
Néphrologie & Thérapeutique , 06/09/09
The Impact of Type 2 Diabetes on Mortality in End-Stage Renal Disease Patients Differs between Genders
Nephron: Clinical Practice, 06/17/09
Today in Nephropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Forced Euvolemic Diuresis With Mannitol and Furosemide for Prevention of Contrast-Induced Nephropathy in Patients With CKD Undergoing Coronary Angiography: A Randomized Controlled Trial - Corrected Proof
American Journal of Kidney Diseases, 06/19/09
Efficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials
American Journal of Nephrology, 06/23/09
Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
New England Journal of Medicine, 07/02/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Forced Euvolemic Diuresis With Mannitol and Furosemide for Prevention of Contrast-Induced Nephropathy in Patients With CKD Undergoing Coronary Angiography: A Randomized Controlled Trial - Corrected Proof
American Journal of Kidney Diseases, 06/19/09
Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
American Journal of Kidney Diseases, 06/23/09
Efficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials
American Journal of Nephrology, 06/23/09
Article Search
Sponsor